Epinephrine
Internal ID | 7d6aa7cd-bdb3-43dc-a941-666f30e540e8 |
Taxonomy | Benzenoids > Phenols > Benzenediols > Catechols |
IUPAC Name | 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol |
SMILES (Canonical) | CNCC(C1=CC(=C(C=C1)O)O)O |
SMILES (Isomeric) | CNC[C@@H](C1=CC(=C(C=C1)O)O)O |
InChI | InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1 |
InChI Key | UCTWMZQNUQWSLP-VIFPVBQESA-N |
Popularity | 138,704 references in papers |
Molecular Formula | C9H13NO3 |
Molecular Weight | 183.20 g/mol |
Exact Mass | 183.08954328 g/mol |
Topological Polar Surface Area (TPSA) | 72.70 Ų |
XlogP | -1.40 |
Atomic LogP (AlogP) | 0.35 |
H-Bond Acceptor | 4 |
H-Bond Donor | 4 |
Rotatable Bonds | 3 |
l-Adrenaline |
adrenaline |
L-epinephrine |
51-43-4 |
Adrenalin |
Levoepinephrine |
Nephridine |
Adnephrine |
Chelafrin |
Epinefrina |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9802 | 98.02% |
Caco-2 | - | 0.9373 | 93.73% |
Blood Brain Barrier | - | 0.7000 | 70.00% |
Human oral bioavailability | - | 0.5571 | 55.71% |
Subcellular localzation | Mitochondria | 0.7131 | 71.31% |
OATP2B1 inhibitior | - | 0.8625 | 86.25% |
OATP1B1 inhibitior | + | 0.9457 | 94.57% |
OATP1B3 inhibitior | + | 0.9588 | 95.88% |
MATE1 inhibitior | - | 1.0000 | 100.00% |
OCT2 inhibitior | - | 1.0000 | 100.00% |
BSEP inhibitior | - | 0.9880 | 98.80% |
P-glycoprotein inhibitior | - | 0.9810 | 98.10% |
P-glycoprotein substrate | - | 0.9363 | 93.63% |
CYP3A4 substrate | - | 0.7865 | 78.65% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | + | 0.5000 | 50.00% |
CYP3A4 inhibition | - | 0.9121 | 91.21% |
CYP2C9 inhibition | - | 0.9563 | 95.63% |
CYP2C19 inhibition | - | 0.9451 | 94.51% |
CYP2D6 inhibition | - | 0.9638 | 96.38% |
CYP1A2 inhibition | - | 0.7862 | 78.62% |
CYP2C8 inhibition | - | 0.9609 | 96.09% |
CYP inhibitory promiscuity | - | 0.9516 | 95.16% |
UGT catelyzed | + | 0.8000 | 80.00% |
Carcinogenicity (binary) | - | 0.8108 | 81.08% |
Carcinogenicity (trinary) | Non-required | 0.7037 | 70.37% |
Eye corrosion | - | 0.8952 | 89.52% |
Eye irritation | - | 0.9541 | 95.41% |
Skin irritation | - | 0.6097 | 60.97% |
Skin corrosion | - | 0.6947 | 69.47% |
Ames mutagenesis | - | 0.9800 | 98.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.6998 | 69.98% |
Micronuclear | - | 0.6968 | 69.68% |
Hepatotoxicity | - | 0.7875 | 78.75% |
skin sensitisation | - | 0.5367 | 53.67% |
Respiratory toxicity | + | 0.9778 | 97.78% |
Reproductive toxicity | + | 0.7889 | 78.89% |
Mitochondrial toxicity | + | 1.0000 | 100.00% |
Nephrotoxicity | - | 0.8507 | 85.07% |
Acute Oral Toxicity (c) | II | 0.5282 | 52.82% |
Estrogen receptor binding | - | 0.8012 | 80.12% |
Androgen receptor binding | - | 0.7439 | 74.39% |
Thyroid receptor binding | - | 0.5318 | 53.18% |
Glucocorticoid receptor binding | - | 0.6491 | 64.91% |
Aromatase binding | - | 0.8033 | 80.33% |
PPAR gamma | - | 0.9017 | 90.17% |
Honey bee toxicity | - | 0.8548 | 85.48% |
Biodegradation | - | 0.6250 | 62.50% |
Crustacea aquatic toxicity | - | 0.6100 | 61.00% |
Fish aquatic toxicity | - | 0.8636 | 86.36% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL3577 | P00352 | Aldehyde dehydrogenase 1A1 |
14125.4 nM |
Potency |
via CMAUP
|
CHEMBL229 | P35348 | Alpha-1a adrenergic receptor |
400 nM |
EC50 |
PMID: 2845082
|
CHEMBL232 | P35368 | Alpha-1b adrenergic receptor |
75 nM |
EC50 |
via Super-PRED
|
CHEMBL223 | P25100 | Alpha-1d adrenergic receptor |
449 nM |
IC50 |
via CMAUP
|
CHEMBL1867 | P08913 | Alpha-2a adrenergic receptor |
737 nM |
IC50 |
via CMAUP
|
CHEMBL1942 | P18089 | Alpha-2b adrenergic receptor |
869 nM |
IC50 |
via CMAUP
|
CHEMBL1916 | P18825 | Alpha-2c adrenergic receptor |
2449 nM |
IC50 |
via CMAUP
|
CHEMBL3687 | P18054 | Arachidonate 12-lipoxygenase |
28183.8 nM |
Potency |
via CMAUP
|
CHEMBL1293236 | P46063 | ATP-dependent DNA helicase Q1 |
17782.8 nM 112201.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL213 | P08588 | Beta-1 adrenergic receptor |
290 nM |
EC50 |
via Super-PRED
|
CHEMBL210 | P07550 | Beta-2 adrenergic receptor |
284 nM 360 nM |
IC50 Ki |
via CMAUP
via Super-PRED |
CHEMBL246 | P13945 | Beta-3 adrenergic receptor |
31 nM 31 nM 49 nM |
EC50 EC50 EC50 |
PMID: 18083578
via Super-PRED PMID: 18083578 |
CHEMBL3356 | P05177 | Cytochrome P450 1A2 |
15848.93 nM |
AC50 |
via CMAUP
|
CHEMBL289 | P10635 | Cytochrome P450 2D6 |
39810.7 nM |
Potency |
via CMAUP
|
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
31622.8 nM 31622.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL217 | P14416 | Dopamine D2 receptor |
910 nM 910 nM |
Ki Ki |
via Super-PRED
PMID: 27132867 |
CHEMBL4159 | Q99714 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
794.3 nM 794.3 nM |
Potency Potency |
via CMAUP
via Super-PRED |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha |
1584.9 nM 1584.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293226 | B2RXH2 | Lysine-specific demethylase 4D-like |
7079.5 nM |
Potency |
via CMAUP
|
CHEMBL4040 | P28482 | MAP kinase ERK2 |
3981.1 nM |
Potency |
via CMAUP
|
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
12589.3 nM 7943.3 nM 11220.2 nM 14125.4 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR |
23280.9 nM 26121.6 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1963 | P16473 | Thyroid stimulating hormone receptor |
31622.8 nM 31622.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
3162.3 nM 794.3 nM 3548.1 nM |
Potency Potency Potency |
via CMAUP
via Super-PRED via CMAUP |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.10% | 91.11% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 95.97% | 85.14% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 94.35% | 96.09% |
CHEMBL2581 | P07339 | Cathepsin D | 92.22% | 98.95% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 88.58% | 91.49% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 87.78% | 99.15% |
CHEMBL3401 | O75469 | Pregnane X receptor | 87.11% | 94.73% |
CHEMBL4208 | P20618 | Proteasome component C5 | 87.09% | 90.00% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 84.15% | 94.45% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.